Long-Term Treatment of Atopic Dermatitis

Area of Science:

• Dermatology
• Immunology
• Clinical Trials

Background:

• Atopic dermatitis (AD) management for mild to moderate cases involves allergen avoidance, moisturization, and topical treatments.
• Limited consensus exists on the optimal next steps for patients with refractory or severe AD.
• Many systemic therapies used off-label in the US lack robust long-term safety and efficacy data.

Purpose of the Study:

• To review long-term randomized controlled trials (RCTs) evaluating safety and/or efficacy of interventions for mild to severe atopic dermatitis.
• To inform clinical decision-making regarding systemic therapies for AD.

Main Methods:

• Systematic review of long-term randomized controlled trials.
• Focus on interventions for atopic dermatitis (AD).
• Analysis of safety and efficacy data.

Main Results:

• Review encompasses various systemic therapies including phototherapy, cyclosporine, mycophenolic acid precursors, azathioprine, and methotrexate.
• Emphasis on data from well-designed, long-term trials.
• Identifies gaps in evidence for current off-label systemic treatments.

Conclusions:

• Evidence from long-term RCTs is crucial for guiding the selection of systemic therapies in atopic dermatitis.
• Further research is needed to establish definitive safety and efficacy profiles for off-label AD treatments.
• Optimizing AD management requires a stronger evidence base for systemic interventions.